ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $649,000 | -6.6% | 6,984 | -40.2% | 0.00% | -50.0% |
Q3 2021 | $695,000 | -11.8% | 11,680 | +1.1% | 0.00% | 0.0% |
Q2 2021 | $788,000 | -2.5% | 11,556 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $808,000 | -12.1% | 11,656 | -2.6% | 0.00% | -33.3% |
Q4 2020 | $919,000 | +15.0% | 11,971 | +12.0% | 0.00% | 0.0% |
Q3 2020 | $799,000 | +37.8% | 10,688 | +15.9% | 0.00% | +50.0% |
Q2 2020 | $580,000 | +83.0% | 9,218 | +21.8% | 0.00% | +100.0% |
Q1 2020 | $317,000 | +18.3% | 7,568 | +28.1% | 0.00% | 0.0% |
Q4 2019 | $268,000 | -0.4% | 5,908 | +0.2% | 0.00% | 0.0% |
Q3 2019 | $269,000 | -31.4% | 5,897 | -11.9% | 0.00% | -50.0% |
Q2 2019 | $392,000 | +41.5% | 6,693 | +8.3% | 0.00% | +100.0% |
Q1 2019 | $277,000 | +22.0% | 6,182 | +5.6% | 0.00% | 0.0% |
Q4 2018 | $227,000 | -15.6% | 5,852 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $269,000 | +15.0% | 5,852 | +9.3% | 0.00% | 0.0% |
Q2 2018 | $234,000 | +4.0% | 5,356 | -6.2% | 0.00% | 0.0% |
Q1 2018 | $225,000 | – | 5,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |